DK2253701T3 - Fremgangsmåde til ekstraktion af en virus fra en cellekultur - Google Patents

Fremgangsmåde til ekstraktion af en virus fra en cellekultur

Info

Publication number
DK2253701T3
DK2253701T3 DK10171853.4T DK10171853T DK2253701T3 DK 2253701 T3 DK2253701 T3 DK 2253701T3 DK 10171853 T DK10171853 T DK 10171853T DK 2253701 T3 DK2253701 T3 DK 2253701T3
Authority
DK
Denmark
Prior art keywords
virus
extracting
cell culture
culture
cell
Prior art date
Application number
DK10171853.4T
Other languages
English (en)
Inventor
Matthew Coffey
Bradley Thompson
Original Assignee
Oncolytics Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc
Application granted granted Critical
Publication of DK2253701T3 publication Critical patent/DK2253701T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/765—Reovirus; Rotavirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12251—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK10171853.4T 2001-03-16 2002-03-11 Fremgangsmåde til ekstraktion af en virus fra en cellekultur DK2253701T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27673401P 2001-03-16 2001-03-16
EP02708064A EP1370643A1 (en) 2001-03-16 2002-03-11 Method of extracting virus from cell culture

Publications (1)

Publication Number Publication Date
DK2253701T3 true DK2253701T3 (da) 2014-10-20

Family

ID=29420186

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10171853.4T DK2253701T3 (da) 2001-03-16 2002-03-11 Fremgangsmåde til ekstraktion af en virus fra en cellekultur

Country Status (14)

Country Link
US (2) US6808916B2 (da)
EP (2) EP2253701B1 (da)
JP (2) JP4087712B2 (da)
AR (1) AR034216A1 (da)
BR (1) BR0207527A (da)
CA (1) CA2437962C (da)
DK (1) DK2253701T3 (da)
ES (1) ES2500645T3 (da)
HK (1) HK1150859A1 (da)
IL (2) IL157304A0 (da)
MX (1) MXPA03007535A (da)
NZ (1) NZ527525A (da)
WO (1) WO2002074940A1 (da)
ZA (1) ZA200306228B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1501921B2 (en) * 2002-04-30 2012-07-25 Oncolytics Biotech Inc. Improved viral purification methods
EP1634947A4 (en) * 2003-06-10 2007-10-03 Shimadzu Corp EXTRACT FROM A CULTURED MAMMALIAN CELL, PROCESS FOR THEIR PREPARATION AND METHOD FOR CELL-FREE PROTEIN SYNTHESIS USING THE EXTRACT
US7901921B2 (en) * 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
US10668119B2 (en) 2005-08-01 2020-06-02 Virocure, Inc. Attenuated reovirus
EP1917351A4 (en) 2005-08-01 2009-12-16 Univ Technologies Int ATTENUATED REOVIRUS
JP5577103B2 (ja) 2007-03-12 2014-08-20 オンコリティクス バイオテク，インコーポレーテッド 改変配列を有するレオウイルス
US10369171B2 (en) 2007-03-13 2019-08-06 Virocure, Inc. Attenuated reoviruses for selection of cell populations
TW200909581A (en) * 2007-05-21 2009-03-01 Oncolytics Biotech Inc Mutant reoviruses and methods of making and using
WO2009052617A1 (en) * 2007-10-22 2009-04-30 Oncolytics Biotech Inc. Treatment regime for proliferative disorders
CN201163385Y (zh) * 2008-01-15 2008-12-10 昆山渝榕电子有限公司 笔记本电脑及其脚垫
US8470312B2 (en) * 2008-05-27 2013-06-25 Oncolytics Biotech, Inc. Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
MX339014B (es) * 2008-05-27 2016-05-09 Oncolytics Biotech Inc Modulacion de presion intersticial y suministro y distribucion viral oncolitica.
EA201390810A1 (ru) 2010-12-02 2013-09-30 Онколитикс Байотек Инк. Жидкие вирусные составы
CN103269716B (zh) 2010-12-02 2015-05-27 昂科利蒂克斯生物科技公司 冻干病毒制剂
KR102151890B1 (ko) 2011-04-29 2020-09-03 온콜리틱스 바이오테크 인코포레이티드 겔 침투 크로마토그래피를 이용한 바이러스의 정제방법
EP2970857A4 (en) * 2013-03-15 2016-11-02 Ansun Biopharma Inc NEW PROTEIN PURIFICATION PROCESS
ES2796950T3 (es) 2013-11-15 2020-11-30 Oncolytics Biotech Inc Virus oncolíticos y regímenes reforzados para tratamiento de cáncer
WO2016130569A1 (en) * 2015-02-09 2016-08-18 Mj Biologics, Inc. A composition comprising pedv antigens and methods for making and using the composition
US10280199B2 (en) 2014-02-07 2019-05-07 Phibro Animal Health Corporation Coronavirus proteins and antigens
EP3172317B1 (en) 2014-07-24 2019-05-01 Janssen Vaccines & Prevention B.V. Process for the purification of poliovirus from cell cultures
GB201417042D0 (en) * 2014-09-29 2014-11-12 Fkd Therapies Oy Method
WO2023277173A1 (ja) * 2021-06-30 2023-01-05 旭化成メディカル株式会社 ウイルスの回収方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
JPS6344532A (ja) 1986-08-11 1988-02-25 Biseibutsu Kagaku Kenkyusho:Kk 豚のレオウイルス感染症ワクチン
US5614413A (en) * 1993-07-01 1997-03-25 The Uab Research Foundation Encapsidated recombinant poliovirus nucleic acid and methods of making and using same
HRP950097A2 (en) * 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
EP0968284B1 (en) * 1996-11-20 2006-12-13 Introgen Therapeutics, Inc. An improved method for the production and purification of adenoviral vectors
US6214333B1 (en) * 1997-07-08 2001-04-10 Texas Heart Institute Vasoprotective recombinant adenovirus vector containing a human TFPI gene
US6110461A (en) 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
TWI289158B (en) * 2000-08-10 2007-11-01 Oncolytics Biotech Inc Method of producing infectious reovirus

Also Published As

Publication number Publication date
JP4087712B2 (ja) 2008-05-21
JP2007295937A (ja) 2007-11-15
HK1150859A1 (en) 2012-01-13
CA2437962C (en) 2005-11-15
ZA200306228B (en) 2004-08-12
ES2500645T3 (es) 2014-09-30
US6808916B2 (en) 2004-10-26
WO2002074940A1 (en) 2002-09-26
US20020168764A1 (en) 2002-11-14
US20050095692A1 (en) 2005-05-05
MXPA03007535A (es) 2003-12-11
JP2004520841A (ja) 2004-07-15
EP2253701B1 (en) 2014-08-13
IL157304A (en) 2010-04-29
US7186542B2 (en) 2007-03-06
EP2253701A1 (en) 2010-11-24
IL157304A0 (en) 2004-02-19
EP1370643A1 (en) 2003-12-17
NZ527525A (en) 2005-03-24
BR0207527A (pt) 2004-02-25
AR034216A1 (es) 2004-02-04
CA2437962A1 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
DK2253701T3 (da) Fremgangsmåde til ekstraktion af en virus fra en cellekultur
DK1349918T3 (da) Fremgangsmåde til indsamling af stamceller fra moderkagen
IS7992A (is) Dýralaus frumuræktunar aðferð
DK1360287T4 (da) Fremgangsmåder til modifikation af eukaryotiske celler
DK2574662T3 (da) Fremgangsmåde til elektroporation af biologiske prøver
DK1743939T3 (da) Fremgangsmåde til isolering af RNA fra formalinfikserede, paraffinindlejrede vævsprøver
IL164551A (en) Method for producing a virus from a cell culture
IS6316A (is) Aðferð til erfðafræðilegra greininga
DK1536810T3 (da) Ekstrahering af farmaceutisk aktive cannabinoider fra plantematerialer
DK1642026T3 (da) Fremgangsmåde til drift af et vindenergianlæg
DK1692295T3 (da) Immobilisering af enzymer ved template-styret silikatpræcipitation
DK1529072T3 (da) Fremgangsmåder til ekstraktion af polymere
DK2135957T3 (da) Fremgangsmåde til fremstilling af glucaner
IS6521A (is) Aðferð til að hreinsa gerjunarseyði
DK1244702T3 (da) Fremgangsmåde til udvinding af osteopontin fra mælk
DK1308198T3 (da) Fremgangsmåde og system til fjernelse af kviksölv
DK1512324T3 (da) Fremgangsmåde til dearomatisering af materialer stammende fra soja
DK1456281T3 (da) Fremgangsmåde til genvinding af en polymer fra en oplösning
DK1212084T3 (da) Fremgangsmåde til adskillelse af rotavirus-varianter samt levende, svækket rotavirus-vaccine
DK1745844T3 (da) System og fremgangsmåde til bortskaffelse af urenheder
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1362040T3 (da) Fremgangsmåde til fremstilling af mesylater af piperidinderivater
DK1294659T3 (da) Fremgangsmåde til isolering af katamin
DK1505992T3 (da) Fremgangsmåde til reduktion af smerter ved hjælp af oncolytiske vira
DK1306440T3 (da) Fremgangsmåde til forbedring af gentransfer-effektivitet ind i planteceller